Device Trial Radar · NCT02459015
Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions
Last checked: Nov 20, 2026Latest source record: Jun 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
46
Actual
Start
Jun 2015
Primary completion
May 31, 2018
Study completion May 31, 2018
Sponsor
- Lead sponsor
- Medovent GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 1, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical investigation is to confirm the medium- and long-term safety and performance of the chitosan-based nerve guide (Reaxon® Nerve Guide) in comparison to an autologous nerve graft to bridge nerve defects in the finger.
Conditions
- Peripheral Nerve Injuries
Interventions
ImplantationDevice
A peripheral nerve defect up to 26 mm in the finger will be repaired by implantation of either a Reaxon® Nerve Guide or an autologous nerve graft (depending on the randomization group) on day 0.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Static 2-point discrimination (2-PD)Time frame: Primary outcome analysis will be performed from the clinical evaluations at 12 months post-surgery
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Unfallkrankenhaus Berlin
Berlin, Germany
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.